基本情報
- CAS
76081-94-2- 標準SMILES
OCC1OC(OC2C(CO)OC(OC3C(CO)OC(OC4C(CO)OC(O)C(O)C4O)C(O)C3O)C(O)C2O)C(O)C(O)C1O- InChIKey
LUEWUZLMQUOBSB-UHFFFAOYSA-N- 分子式
- C24H42O21
- 平均分子量
- 666.6 g/mol
- 単同位体質量
- 666.22185834
概要
amylotetraose has been reported in Hamamotoa singularis and Aloe maculata with data available.
名称と識別子
- 優先名称
- Amylotetraose; Fujioligo 450; alpha-1,4-Tetraglucose
- IUPAC
- 2-[6-[4,5-dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
- 現地名
- グルコマンナン
- 英語名
- (1-6)-alpha-glucomannan
- 分子式
- C24H42O21
- 分子量
- 666.57768
名称と別名
Amylotetraose; Fujioligo 450; alpha-1,4-Tetraglucose2-[6-[4,5-dihydroxy-2-(hydroxymethyl)-6-[4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol2-(6-(4,5-dihydroxy-2-(hydroxymethyl)-6-(4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl)oxyoxan-3-yl)oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl)oxy-6-(hydroxymethyl)oxane-3,4,5-triolRefChem:584321GlyTouCan:G01007QUG01007QUD-Mannan9036-88-876081-94-2(Hex)4D-CellotetraoseD-(+)-Cellotetraose
名称をさらに表示
6)- (9CI)(1-6)-alpha-glucomannana-D-Gluco-D-mannan, (1®(1-6)-alpha-D-Gluco-D-mannanGlucomannan,(1-6)-alpha-glucomannan
Mannan, Yeast?-D-MaltotetraoseI<<-1,4-Tetraglucose| cent-1,4-TetraglucoseSCHEMBL11981897(3S,4S,5R,6S)-5-{[(2S,3S,4S,5R,6S)-5-{[(2R,3S,4S,5R,6S)-3,4-dihydroxy-6-(hydroxymethyl)-5-{[(2R,3S,4R,5R,6S)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}oxan-2-yl]oxy}-3,4-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-6-(hydroxymethyl)oxane-2,3,4-triolNAA08623s9195
物性
構造計算による物性
- XLogP
- -9
- 極性表面積
- 348 Ų
- 水素結合供与体数
- 14
- 水素結合受容体数
- 21
- 回転可能結合数
- 10
- 重原子数
- 45
- 形式電荷
- 0
- 複雑度
- 918
実験および物理化学的性質
DrugsPharmaceuticals
PolymersBiological Agents -> Polysaccharides
Physical DescriptionBeige powder; [Sigma-Aldrich MSDS]
Collision Cross Section234.8 Ų [M+Na-H2O]+ [CCS Type: DT; Method: stepped-field]
安全と法規制
安全情報は参考情報です。供給元の安全データシート（SDS）、適用法令、専門家による評価に代わるものではありません。
危険有害性情報
Regulatory InformationD-Mannan: Does not have an individual approval but may be used under an appropriate group standard
Hazards SummaryCauses other blood changes and changes in leukocyte counts in acute intravenous studies of mice; Intravenous LD50 (mouse) = 2,000 mg/kg; [RTECS] May cause irritation; [Sigma-Aldrich MSDS]
化学と産業
応用分野
使用Pantothenic acid is useful in treating vertigo, postoperative shock, and poisoning with isoniazid and curare;it is useful in accelerating wound healing; and it is useful in treating Addison’s disease, liver cirrhosis, and diabetes.
調製方法
Pantothenic acid is produced commercially by synthesis involving the condensation of d-pantolactone with salt of β-alanine. Some of the dietary supplement forms include calcium pantothenate, dexpanthenol, and panthenol.
上流・下流製品情報
上流原料
サプライヤー4 社
成都标样生物科技有限公司028-81700200 13308200041 · [email protected]
湖州浦瑞生物医药技术有限公司0572-2745768-1 13167223168;13167223168 · [email protected]
湖北玖天生物医药科技有限公司027-88013699 17354350817 · [email protected]
湖州浦瑞生物医药技术有限公司+86-0572-2745768 +86-13816075732 · [email protected]
補足説明
定義本品は、グルコースの側鎖を有するマンノース(*)の重合体である。参照表示名称：マンノース
関連反応
0 件
現在のフィルター条件では反応記録がありません。
化合物ノート
読み込み中…